Central sensitisation in chronic low back pain: A cross-sectional study.
Nagma Sheenam, Ravi Gaur, Nitesh Manohar Gonnade...
https://pubmed.ncbi.nlm.nih.gov/40979767/Actively Recruiting
Led by Mardin Artuklu University · Updated on 2026-09-17
180
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are investigating whether signs of increased sensitivity in the nervous system, measured by the Central Sensitization Inventory CSI, can predict short-term clinical outcomes in adults with chronic nonspecific low back pain. This observational study focuses on understanding how initial nervous system sensitivity relates to disability, pain, and perceived treatment benefit in patients. Approximately 180 adults aged 18 to 65 with chronic nonspecific low back pain lasting at least three months will participate. Participants will complete questionnaires at the start of the study, including the CSI, Oswestry Disability Index ODI for disability, a pain scale, and an anxiety and depression scale. They will then continue their usual clinical care as determined by their doctors. After six weeks, researchers will reassess disability, pain, and overall perception of improvement to analyze the relationship between initial central sensitization and clinical changes during this period. During the study, participants will be asked to fill out questionnaires at baseline and again after six weeks. Researchers will collect data on disability, pain intensity, and patient-perceived improvement to evaluate treatment outcomes. No study treatment will be assigned, and participants will receive routine care throughout. The main outcome measured is a clinically meaningful improvement in disability after six weeks, with safety and progress monitored through these assessments.
CONDITIONS
Is Central Sensitization a Prognostic Indicator in Chronic Nonspecific Low Back Pain?
T
Taha Yasin YILDIRIM, M.D.
H
Hatice Gözde Sümer, M.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Mardin Artuklu University
Lead Sponsor
Mardin Training and Research Hospital
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 6 weeks
Participants complete questionnaires about pain, disability, anxiety, and depression at the start and after six weeks while continuing their usual clinical care.
2 assessment visits
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Nagma Sheenam, Ravi Gaur, Nitesh Manohar Gonnade...
https://pubmed.ncbi.nlm.nih.gov/40979767/Jo Nijs, Steven Z George, Daniel J Clauw...
https://pubmed.ncbi.nlm.nih.gov/38279393/Clifford J Woolf
https://pubmed.ncbi.nlm.nih.gov/20961685/Mardin Artuklu University
Lead Sponsor
Mardin Training and Research Hospital
Collaborating Sponsor